鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/05/08 | 3,275 | 3,360 | 3,275 | 3,295 | -5 | -0.2% | 53,500 |
| 2023/05/02 | 3,350 | 3,365 | 3,285 | 3,300 | -45 | -1.3% | 37,800 |
| 2023/05/01 | 3,305 | 3,390 | 3,300 | 3,345 | -100 | -2.9% | 65,400 |
| 2023/04/28 | 3,445 | 3,515 | 3,415 | 3,445 | +50 | +1.5% | 91,400 |
| 2023/04/27 | 3,405 | 3,435 | 3,385 | 3,395 | +10 | +0.3% | 26,400 |
| 2023/04/26 | 3,400 | 3,430 | 3,380 | 3,385 | -5 | -0.1% | 39,800 |
| 2023/04/25 | 3,355 | 3,430 | 3,355 | 3,390 | +45 | +1.3% | 58,900 |
| 2023/04/24 | 3,375 | 3,375 | 3,330 | 3,345 | -5 | -0.1% | 39,500 |
| 2023/04/21 | 3,285 | 3,370 | 3,275 | 3,350 | +65 | +2% | 77,300 |
| 2023/04/20 | 3,270 | 3,290 | 3,250 | 3,285 | +50 | +1.5% | 53,500 |
| 2023/04/19 | 3,235 | 3,255 | 3,220 | 3,235 | -35 | -1.1% | 17,600 |
| 2023/04/18 | 3,280 | 3,295 | 3,260 | 3,270 | ±0 | ±0% | 15,300 |
| 2023/04/17 | 3,300 | 3,300 | 3,255 | 3,270 | -5 | -0.2% | 23,000 |
| 2023/04/14 | 3,250 | 3,280 | 3,240 | 3,275 | +35 | +1.1% | 33,900 |
| 2023/04/13 | 3,260 | 3,265 | 3,225 | 3,240 | -10 | -0.3% | 32,300 |
| 2023/04/12 | 3,240 | 3,260 | 3,225 | 3,250 | +15 | +0.5% | 32,600 |
| 2023/04/11 | 3,225 | 3,250 | 3,185 | 3,235 | +10 | +0.3% | 33,200 |
| 2023/04/10 | 3,195 | 3,225 | 3,185 | 3,225 | +30 | +0.9% | 21,700 |
| 2023/04/07 | 3,160 | 3,195 | 3,160 | 3,195 | +40 | +1.3% | 17,600 |
| 2023/04/06 | 3,115 | 3,160 | 3,110 | 3,155 | -10 | -0.3% | 29,300 |
| 2023/04/05 | 3,240 | 3,245 | 3,165 | 3,165 | -130 | -3.9% | 35,400 |
| 2023/04/04 | 3,205 | 3,325 | 3,200 | 3,295 | +125 | +3.9% | 65,500 |
| 2023/04/03 | 3,190 | 3,205 | 3,155 | 3,170 | -10 | -0.3% | 19,400 |
| 2023/03/31 | 3,165 | 3,190 | 3,165 | 3,180 | +35 | +1.1% | 27,100 |
| 2023/03/30 | 3,170 | 3,180 | 3,135 | 3,145 | -10 | -0.3% | 23,600 |
| 2023/03/29 | 3,130 | 3,160 | 3,125 | 3,155 | +55 | +1.8% | 39,800 |
| 2023/03/28 | 3,070 | 3,125 | 3,070 | 3,100 | +30 | +1% | 36,000 |
| 2023/03/27 | 3,070 | 3,085 | 3,055 | 3,070 | +10 | +0.3% | 12,000 |
| 2023/03/24 | 3,015 | 3,065 | 3,015 | 3,060 | +5 | +0.2% | 14,800 |
| 2023/03/23 | 3,075 | 3,075 | 3,030 | 3,055 | -25 | -0.8% | 24,200 |
| 2023/03/22 | 3,105 | 3,135 | 3,070 | 3,080 | +5 | +0.2% | 27,600 |
| 2023/03/20 | 3,135 | 3,135 | 3,065 | 3,075 | -80 | -2.5% | 24,800 |
| 2023/03/17 | 3,145 | 3,185 | 3,145 | 3,155 | +5 | +0.2% | 16,700 |
| 2023/03/16 | 3,170 | 3,190 | 3,140 | 3,150 | -55 | -1.7% | 25,600 |
| 2023/03/15 | 3,210 | 3,230 | 3,180 | 3,205 | +5 | +0.2% | 30,100 |
| 2023/03/14 | 3,185 | 3,245 | 3,160 | 3,200 | -30 | -0.9% | 28,700 |
| 2023/03/13 | 3,290 | 3,290 | 3,205 | 3,230 | -60 | -1.8% | 25,900 |
| 2023/03/10 | 3,215 | 3,330 | 3,215 | 3,290 | +15 | +0.5% | 43,100 |
| 2023/03/09 | 3,260 | 3,295 | 3,245 | 3,275 | +40 | +1.2% | 23,200 |
| 2023/03/08 | 3,210 | 3,255 | 3,190 | 3,235 | +25 | +0.8% | 17,900 |
| 2023/03/07 | 3,250 | 3,280 | 3,195 | 3,210 | -25 | -0.8% | 25,500 |
| 2023/03/06 | 3,225 | 3,285 | 3,200 | 3,235 | +50 | +1.6% | 43,400 |
| 2023/03/03 | 3,135 | 3,195 | 3,135 | 3,185 | +40 | +1.3% | 22,800 |
| 2023/03/02 | 3,140 | 3,155 | 3,130 | 3,145 | +40 | +1.3% | 11,700 |
| 2023/03/01 | 3,105 | 3,140 | 3,100 | 3,105 | -35 | -1.1% | 21,100 |
| 2023/02/28 | 3,105 | 3,155 | 3,090 | 3,140 | +15 | +0.5% | 60,100 |
| 2023/02/27 | 3,120 | 3,140 | 3,100 | 3,125 | -20 | -0.6% | 10,200 |
| 2023/02/24 | 3,185 | 3,185 | 3,130 | 3,145 | -55 | -1.7% | 29,700 |
| 2023/02/22 | 3,265 | 3,265 | 3,180 | 3,200 | -65 | -2% | 24,300 |
| 2023/02/21 | 3,275 | 3,285 | 3,255 | 3,265 | +10 | +0.3% | 12,400 |
501～
550
件表示中 / 3704件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| サワイＧＨＤ | 189,200円 | +5.9% | +24.5% | 2.91% | 12.56倍 | 1.18倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 387,000円 | +3.6% | +6.1% | 3.10% | 13.04倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 300,500円 | +7.9% | -3.3% | 2.66% | 8.36倍 | 0.87倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
